Skip to main content
Premium Trial:

Request an Annual Quote

Edward Koval, Mark Adams, James Aswell, Bill Rutter, Stelios Papadopoulos

Premium

Variagenics of Cambridge, Mass., has promoted Edward Koval, previously senior director of business development, to vice president of corporate and strategic development and Mark Adams, previously senior director, to vice president of bioinformatics.

The company has also hired James Aswell as senior director of diagnostics, a newly created position. Aswell was formerly senior staff scientist at Bayer Diagnostics.

Bill Rutter and Stelios Papadopoulos have been appointed to the board of directors of San Diego-based Structural GenomiX, increasing the board to eight members.

Rutter is a founder and chairman emeritus of Chiron and also a founder of Prospect Genomics, which was recently acquired by Structural GenomiX.

Papadopoulos is a managing director in the investment banking division at SG Cowen.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.